Novel Approaches for the Early Detection of Glaucoma Using Artificial Intelligence.
| Title: | Novel Approaches for the Early Detection of Glaucoma Using Artificial Intelligence. |
|---|---|
| Authors: | Zeppieri M; Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.; Gardini L; Unit of Ophthalmology, Department of Surgical Sciences, Ospedale Maggiore, 40100 Bologna, Italy.; Culiersi C; Unit of Ophthalmology, Department of Surgical Sciences, Ospedale Maggiore, 40100 Bologna, Italy.; Fontana L; Ophthalmology Unit, Department of Surgical Sciences, IRCCS Azienda Ospedaliero, Alma Mater Studiorum University of Bologna, 40100 Bologna, Italy.; Musa M; Department of Optometry, University of Benin, Benin City 300238, Nigeria.; Africa Eye Laser Centre, Km 7, Benin City 300105, Nigeria.; D'Esposito F; Imperial College Ophthalmic Research Group (ICORG) Unit, Imperial College, 153-173 Marylebone Rd, London NW15QH, UK.; Department of Neurosciences, Reproductive Sciences and Dentistry, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy.; Surico PL; Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA.; Department of Ophthalmology, Campus Bio-Medico University, 00128 Rome, Italy.; Gagliano C; Department of Medicine and Surgery, University of Enna 'Kore', Piazza dell'Università, 94100 Enna, Italy.; Mediterranean Foundation 'G.B. Morgagni', 95125 Catania, Italy.; Sorrentino FS; Unit of Ophthalmology, Department of Surgical Sciences, Ospedale Maggiore, 40100 Bologna, Italy. |
| Source: | Life (Basel, Switzerland) [Life (Basel)] 2024 Oct 28; Vol. 14 (11). Date of Electronic Publication: 2024 Oct 28. |
| Publication Type: | Journal Article; Review |
| Language: | English |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101580444 Publication Model: Electronic Cited Medium: Print ISSN: 2075-1729 (Print) Linking ISSN: 20751729 NLM ISO Abbreviation: Life (Basel) Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: Basel, Switzerland : MDPI AG, 2011- |
| Abstract: | Background: If left untreated, glaucoma-the second most common cause of blindness worldwide-causes irreversible visual loss due to a gradual neurodegeneration of the retinal ganglion cells. Conventional techniques for identifying glaucoma, like optical coherence tomography (OCT) and visual field exams, are frequently laborious and dependent on subjective interpretation. Through the fast and accurate analysis of massive amounts of imaging data, artificial intelligence (AI), in particular machine learning (ML) and deep learning (DL), has emerged as a promising method to improve the early detection and management of glaucoma.; Aims: The purpose of this study is to examine the current uses of AI in the early diagnosis, treatment, and detection of glaucoma while highlighting the advantages and drawbacks of different AI models and algorithms. In addition, it aims to determine how AI technologies might transform glaucoma treatment and suggest future lines of inquiry for this area of study.; Methods: A thorough search of databases, including Web of Science, PubMed, and Scopus, was carried out to find pertinent papers released until August 2024. The inclusion criteria were limited to research published in English in peer-reviewed publications that used AI, ML, or DL to diagnose or treat glaucoma in human subjects. Articles were chosen and vetted according to their quality, contribution to the field, and relevancy.; Results: Convolutional neural networks (CNNs) and other deep learning algorithms are among the AI models included in this paper that have been shown to have excellent sensitivity and specificity in identifying glaucomatous alterations in fundus photos, OCT scans, and visual field tests. By automating standard screening procedures, these models have demonstrated promise in distinguishing between glaucomatous and healthy eyes, forecasting the course of the disease, and possibly lessening the workload of physicians. Nonetheless, several significant obstacles remain, such as the requirement for various training datasets, outside validation, decision-making transparency, and handling moral and legal issues.; Conclusions: Artificial intelligence (AI) holds great promise for improving the diagnosis and treatment of glaucoma by facilitating prompt and precise interpretation of imaging data and assisting in clinical decision making. To guarantee wider accessibility and better patient results, future research should create strong generalizable AI models validated in various populations, address ethical and legal matters, and incorporate AI into clinical practice. |
| References: | JAMA. 2017 Dec 12;318(22):2211-2223. (PMID: 29234807); Curr Opin Ophthalmol. 2020 Sep;31(5):329-336. (PMID: 32740060); Diagnostics (Basel). 2024 Jun 18;14(12):. (PMID: 38928700); Ophthalmology. 2016 Dec;123(12):2571-2580. (PMID: 27726962); Ophthalmology. 2018 Aug;125(8):1199-1206. (PMID: 29506863); Eye (Lond). 2020 Jan;34(1):1-11. (PMID: 31541215); Invest Ophthalmol Vis Sci. 2013 May 13;54(5):3417-25. (PMID: 23532529); Br J Ophthalmol. 2006 Mar;90(3):262-7. (PMID: 16488940); Ophthalmology. 2014 Nov;121(11):2081-90. (PMID: 24974815); Biomed Eng Online. 2023 Dec 16;22(1):126. (PMID: 38102597); J Curr Glaucoma Pract. 2013 Sep-Dec;7(3):106-14. (PMID: 26997792); Am J Ophthalmol. 2019 Dec;208:30-40. (PMID: 31323204); Diagnostics (Basel). 2021 Mar 13;11(3):. (PMID: 33805685); Artif Intell Med. 2005 Jun;34(2):163-77. (PMID: 15894180); Br J Ophthalmol. 2003 Jun;87(6):726-30. (PMID: 12770970); Expert Rev Ophthalmol. 2016;11(5):367-376. (PMID: 28603546); Am J Ophthalmol. 2021 Jul;227:74-86. (PMID: 33497675); Nature. 2015 May 28;521(7553):436-44. (PMID: 26017442); J R Soc Interface. 2015 Feb 6;12(103):. (PMID: 25505132); Ophthalmology. 2021 Jul;128(7):1016-1026. (PMID: 33359887); Lancet. 2017 Nov 11;390(10108):2183-2193. (PMID: 28577860); Ophthalmology. 2016 Sep;123(9):1974-80. (PMID: 27395766); J Healthc Eng. 2019 Feb 18;2019:4061313. (PMID: 30911364); Clin Ophthalmol. 2020 Feb 13;14:419-429. (PMID: 32103888); Invest Ophthalmol Vis Sci. 2018 Jun 1;59(7):2748-2756. (PMID: 29860461); Ophthalmology. 2018 Mar;125(3):352-360. (PMID: 29103791); Methods. 2022 Jun;202:14-21. (PMID: 34153436); Multimed Tools Appl. 2022;81(19):27737-27781. (PMID: 35368855); Am Fam Physician. 1995 Dec;52(8):2289-98, 2303-4. (PMID: 7484722); Ann Biomed Eng. 2023 May;51(5):868-869. (PMID: 36920578); Int J Ophthalmol. 2024 Mar 18;17(3):408-419. (PMID: 38721504); Medicina (Kaunas). 2023 Dec 03;59(12):. (PMID: 38138217); Transl Vis Sci Technol. 2022 Mar 02;11(3):4. (PMID: 35254422); Am J Ophthalmol. 2018 Sep;193:71-79. (PMID: 29920226); Ophthalmology. 2011 Jan;118(1):60-5. (PMID: 20723992); Surv Ophthalmol. 2023 Jan-Feb;68(1):17-41. (PMID: 35985360); Arch Ophthalmol. 2002 Jun;120(6):701-13; discussion 829-30. (PMID: 12049574); J Pak Med Assoc. 2023 Dec;73(12):2509-2510. (PMID: 38083947); Lancet Digit Health. 2020 Jan;2(1):e8-e9. (PMID: 33328040); Ophthalmology. 2020 Jun;127(6):731-738. (PMID: 32081491); Cureus. 2020 Nov 24;12(11):e11686. (PMID: 33391921) |
| Contributed Indexing: | Keywords: artificial intelligence; deep learning; glaucoma; machine learning; optic disc neuropathy; visual field |
| Entry Date(s): | Date Created: 20241127 Latest Revision: 20241130 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC11595922 |
| DOI: | 10.3390/life14111386 |
| PMID: | 39598184 |
| Database: | MEDLINE |
Journal Article; Review